Namibia Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Namibia Pharmaceuticals and Healthcare Report Q3 2013 May 8th 2013, 00:00 BMI View: We expect Namibia’s negative pharmaceutical trade balance to widen as demand for medicines continues to be met by imports, and poor local manufacturing sees exports contract in the medium term. Headline Expenditure Forecasts ? Pharmaceuticals: NAD2.20bn (US$268mn) in 2012 to NAD2.36bn (US$259mn) in 2013; +7.1% in local currency and -3.3% in US dollar terms. ? Healthcare: NAD5.08bn (US$619mn) in 2012 to NAD5.40bn (US$594mn) in 2013; +6.3% in local currency and -4.0% in US dollar terms. Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=94980. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/namibia-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions